Dashboard
Manage Tickers

MBIOMUSTANG BIO, INC.

Nasdaq mustangbio.com


$ 0.36 $ -0.01 (-2.96 %)    

Friday, 19-Apr-2024 14:43:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 414.44 $ -8.77 (-2.07 %)
DIA $ 379.22 $ 0.74 (0.2 %)
SPY $ 494.87 $ -4.56 (-0.91 %)
TLT $ 89.12 $ -0.24 (-0.27 %)
GLD $ 221.61 $ 1.56 (0.71 %)
$ 0.371
$ 0.38
$ 0.00 x 0
$ 0.00 x 0
$ 0.36 - $ 0.38
$ 0.33 - $ 8.17
211,111
na
3.19M
$ 1.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-11-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-23-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-24-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-16-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-18-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-13-2018 06-30-2018 10-Q
24 05-14-2018 03-31-2018 10-Q
25 03-29-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 12:09:32

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
04/17/2024 20:31:15

mustang-bio-inc-approved-a-reduction-of-its-workforce-by-81-of-its-employee-base-workforce-reduction-will-take-place-primarily-in-april-2024-expected-to-be-substantially-completed-in-q2-of-2024-continue-to-evaluate-all-strategic-and-other-alternatives-related-to-business
Mustang Bio Inc Approved A Reduction Of It...
04/12/2024 20:21:01

- SEC Filing

mustang-bio-expands-car-t-cell-therapy-platform-expansion-into-autoimmune-diseases
Mustang Bio Expands CAR T-Cell Therapy Pla...
03/28/2024 13:03:27

Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy ...

mustang-bio-reports-fy23-eps-of-600-vs-1009-yoy-and-recent-corporate-highlights
Mustang Bio Reports FY23 EPS Of $(6.00) Vs...
03/11/2024 20:24:55

Financial Results: As of December 31, 2023, Mustang's cash and cash equivalents and restricted cash totaled $7.0 million...

why-rush-street-interactive-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket
Why Rush Street Interactive Shares Are Tra...
03/07/2024 13:05:46

Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better...

Core News & Articles
Phase 1 CAR T Cell Therapy Trial For Gliob...
03/07/2024 10:06:54

Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced com...

mustang-bio-presents-updated-phase-12-multicenter-clinical-data-for-mb-106-at-the-2023-ash-annual-meeting
Mustang Bio Presents Updated Phase 1/2 Mul...
12/11/2023 13:37:26

   Data showed favorable safety profile, complete response rate and durability in the treatment of patients with relapsed or re...

mustang-bio-q3-eps-123-misses-111-estimate
Mustang Bio Q3 EPS $(1.23) Misses $(1.11) ...
11/14/2023 22:06:44

Mustang Bio (NASDAQ:MBIO) reported quarterly losses of $(1.23) per share which missed the analyst consensus estimate of $(1.11)...

mustang-bio-announces-mb-106-cd20-targeted-car-t-data-selected-for-presentation-at-65th-ash-annual-meeting
Mustang Bio Announces MB-106 CD20-Targeted...
11/02/2023 13:29:29

why-harley-davidson-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Harley-Davidson Shares Are Trading Low...
10/26/2023 17:27:41

Gainers

mustang-bio-announces-44m-registered-direct-offering-of-2588236-of-its-shares-of-common-stock-at-a-price-of-170share-priced-at-the-market-under-nasdaq-rules
Mustang Bio Announces $4.4M Registered Dir...
10/26/2023 16:31:37

Mustang Bio, Inc. ("Mustang" or the "Company") (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focuse...

mustang-bio-shares-are-trading-higher-after-the-company-announced-the-fda-accepted-its-ind-application-of-mb-109-for-the-treatment-of-recurrent-glioblastoma-and-high-grade-astrocytoma
Mustang Bio shares are trading higher afte...
10/26/2023 16:04:42

mustang-bio-announces-fda-acceptance-of-ind-application-for-mb-109-a-novel-combination-of-mb-101-and-mb-108-for-the-treatment-of-recurrent-glioblastoma-and-high-grade-astrocytoma
Mustang Bio Announces FDA Acceptance Of IN...
10/26/2023 13:06:36

MB‐101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus) are separately well tolerated in patients with ...

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
09/21/2023 16:08:37

  During the session on Thursday, 461 stocks hit new 52-week lows.

stocks-that-hit-52-week-lows-on-tuesday
Stocks That Hit 52-Week Lows On Tuesday
09/19/2023 16:50:48

  During Tuesday's session, 275 companies made new 52-week lows.

hc-wainwright--co-reiterates-buy-on-mustang-bio-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on Must...
08/16/2023 15:59:51

HC Wainwright & Co. analyst Joseph Pantginis reiterates Mustang Bio (NASDAQ:MBIO) with a Buy and maintains $25 price tar...

mustang-bio-announces-first-data-from-ongoing-multicenter-phase-12-clinical-trial-evaluating-mb-106-car-t-cell-therapy-iniital-data-show-clinical-responses-from-four-of-four-indolent--lymphoma-patients
Mustang Bio Announces First Data From Ongo...
08/16/2023 12:03:41

what-4-analyst-ratings-have-to-say-about-mustang-bio
What 4 Analyst Ratings Have To Say About M...
08/15/2023 16:00:39

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)